NCT06629311 Platelet and Autotransfusion Device in Cardiac Surgery
| NCT ID | NCT06629311 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Platelets |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-02-04 |
| Primary Completion | 2026-09-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-02-04 with a primary completion date of 2026-09-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiac surgery is a bleeding-risk surgery and frequently requires blood transfusion. Intraoperative autotransfusion devices are used to aspirate, process and retransfuse patients' blood. These devices are effective in recovering red blood cells and limiting the need for transfusion of packed red blood cells. Some devices, such as I-SEP's SAME®, can also be used to recover platelets, but their effectiveness has not yet been evaluated in real-life situations. The aim of this study is therefore to investigate the evolution of platelet counts following the use of an intraoperative recovery device in adult patients undergoing standard cardiac surgery
Eligibility Criteria
Inclusion Criteria: * Patients over 18 years of age * Having undergone standard cardiac surgery (excluding redux surgery, dissection, endocarditis, circulatory assist and transplants) * Treated with an autotransfusion device during the surgery * Subject having expressed their consent to the study Exclusion Criteria: * Anemia less than 7 g/dL * Pregnant women * Redux surgery, dissection, endocarditis, circulatory assistance, and transplants * Contraindication to the use of an autotransfusion device * Impossibility of giving the subject informed information
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06629311 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Platelets. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06629311 currently recruiting?
Yes, NCT06629311 is actively recruiting participants. Contact the research team at charlesambroise.tacquard@chru-strasbourg.fr for enrollment information.
Where is the NCT06629311 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT06629311 clinical trial?
NCT06629311 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 100 participants.